For the Inventor, By the Inventor

Enter assignee name

New York, NY, United States of America

Warner Lambert LLC

USPTO Granted Patents = 22

Trademarks = 1

Forward Citations = 246

Loading Chart...

Loading Chart...

49 inventors (with patents filed for the assignee):

Patrick Bernardelli (3 out of 9 patents)

Charles Andrianjara (2 out of 3 patents)

Remi Lavalette (2 out of 2 patents)

4. Claude Forsey Purchase, Jr (2 out of 16 patents)

5. Gerald Paul Schielke (2 out of 5 patents)

6. Lary Craswell Walker (2 out of 5 patents)

7. Andrew David White (2 out of 31 patents)

8. Bruce D Roth (2 out of 77 patents)

9. James S Kaltenbronn (2 out of 32 patents)

10. Leonard Doub (2 out of 7 patents)

11. Theodore H Haskell (2 out of 17 patents)

12. Brian Desmond Palmer (1 out of 19 patents)

13. Roger Schofield Newton (1 out of 11 patents)

14. Jonathan Miller (1 out of 37 patents)

15. Gordon William Rewcastle (1 out of 33 patents)

22 patents: Sort by Forward Citations

1. 8383667 - Forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid magnesium (2013-02-26),

2. 7122565 - Thiadiazoles and oxadiazoles and their use as phosphodiesterase-7 inhibitors (2006-10-17),

3. 6962912 - Substituted pyrazolo[4,3-e]diazepines, pharmaceutical compositions containing them, use as medicinal products and processes for preparing them (2005-11-08),

4. 6878821 - Modifying chemoselectivity during oxidation of nitrogen compounds (2005-04-12),

5. 6828315 - 1-Amino triazoloc4,3-a&excl; quinazoline-5-ones and/or -5-thiones inhibiting phosphodiesterase IV (2004-12-07),

6. 6787554 - Triazolo[4,3-a]pyrido[2,3-d]pyrimidin-5-one derivatives (2004-09-07),

7. 6747035 - 1-alkyl or 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors (2004-06-08),

8. 6689881 - Method for preparing substituted [1,4]diazepino[6,7,1-hi]indol-4-ones (2004-02-10),

9. 6395930 - Quenching reagents for solution phase synthesis (2002-05-28),

10. 6265432 - Flourine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases (2001-07-24),

11. 6251919 - Heterocyclic substituted aniline calcium channel blockers (2001-06-26),

12. 6169103 - Fluorine-substituted biphenyl butyric acids and their derivatives as inhibitors of matrix metalloproteinases (2001-01-02),

13. 5877022 - Ribozymes targeted to APO(a) RNA (1999-03-02),

14. 5464861 - 2-thioindoles (selenoindoles) and related disulfides (selenides) which (1995-11-07),

15. 4738981 - Substituted trans-1,2-diaminocyclohexyl amide compounds (1988-04-19),

Warner Lambert LLC is a leading pharmaceutical company that specializes in the development and distribution of a wide range of healthcare products. With a focus on innovation and quality, Warner Lambert LLC is dedicated to improving the health and well-being of individuals around the world. Visit our website to learn more about our products and services.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

22 Patents

#330 in New York, NY

#821 in New York

#14,536 in US

#27,908 in the World

New York, NY, United States of America

Warner Lambert LLC

Forward Citations = 246

49 inventors:

Patrick Bernardelli (3 out of 9 patents)

Charles Andrianjara (2 out of 3 patents)

Remi Lavalette (2 out of 2 patents)

4. Claude Forsey Purchase, Jr (2 out of 16 patents)

5. Gerald Paul Schielke (2 out of 5 patents)

Please report any incorrect information to support@idiyas.com

Loading…